CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Medicina from Universidade Federal de São Paulo (1984) and doctorate at Cardiology from Universidade de São Paulo (1997). Has experience in Medicine, focusing on Cardiology, acting on the following subjects: acute myocardial infarction, infarto agudo do miocárdio, myocardial infarction, hydrogen peroxide and therapy. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Inflammation is an important pillar of atherogenesis in coronary disease. Studies have documented the prognostic power of measuring coronary perivascular adipose tissue attenuation (PVAT) and its good correlation as an early inflammatory biomarker in the atherogenesis process, in addition to being a predictor for cardiovascular events in the future. Colchicine, a medication with well-docu…
The chronic ischemic cardiovascular disease (CICD) is a major cause of morbidity and mortality worldwide. In turn, the Heart Institute - School of Medicine, University of Sao Paulo, Brazil, (InCor) - is a leading cardiovascular hospital in Latin America, contributing to the exponential growth in the number of clinical trials on heart diseases conducted in the region.The primary goals of t…
The prostate cancer, excluding skin malignant disease, shows the higher incidence among all types of cancer in male. There is a progressive increase in its incidence in Brazil, partly justified by evolution in diagnosis methods, better information systems and enlargment of survival. Nearly 86% of the prostate cancer diagnosis are made when the disease still localized and cure reaches 98.8…
(Only some records are available in English at this moment)
Since 2014, a series of clinical trials involving new therapeutic approaches to reduce residual risk in patients with chronic coronary disease (CCD) have been published, demonstrating a significant reduction in cardiovascular events in this population. These therapies involve medications to control LDL-cholesterol, such as PCSK-9 inhibitors, medications for glycemic control such as GLP-1 …
The chronic ischemic cardiovascular disease (CICD) is a major cause of morbidity and mortality worldwide. In turn, the Heart Institute - School of Medicine, University of Sao Paulo, Brazil, (InCor) - is a leading cardiovascular hospital in Latin America, contributing to the exponential growth in the number of clinical trials on heart diseases conducted in the region. The primary goals of …
Assess the androgenic block in prostate cancer as metabolic syndrome cause and as arterial coronary disease risk factor, besides to determinate the outline of the inflammatory, endothelial and thrombotic markers for arterial atherosclerotic disease in patients with prostate cancer with clinical indication for hormonal deprivation by drugs or surgical procedures
The percutaneous coronary intervention causes damage to the arterial wall leading to increased inflammatory markers such as C-reactive protein (CRP), tumor necrosis factor (TNF alpha) and interleukin (IL-1, IL-6 and IL-8). As tissue injury peri-procedure maintains a close relationship with the level of inflammatory activity, we must consider the level of activation of inflammatory cells b…
| 1 / 1 | Ongoing grants |
| 12 / 4 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 13 / 3 | Completed scholarships in Brazil |
| 27 / 9 | All research grants and scholarships |
| Associated processes | |